CDP Capital Technology Ventures

investment firm

About

CDP Capital Technology Ventures is a Quebec-based investment firm that aims to develop new technology-based companies.

  • Montréal,Quebec,Canada

Details

Industries
Finance,Financial Services,Venture Capital
Founded date
Jan 1, 1995
Operating Status
Active
Investor Type
PE

CDP Capital-Technology Ventures is out of business. CDP Capital-Technology Ventures is a principle investment firm specializing in building new technology-based companies. The firm seeks to invest in pre-startup and startup, research and development, mergers & acquisitions, expansion into new markets, and management buyouts. The firm also raises fund of funds that invest in North American and European venture capital funds. The firm seeks to invest in companies engaged in life sciences such as including biotechnology, pharmaceuticals, medical instrumentation; information technology; energy technologies; industrial technologies such as aeronautical and environmental. It also seeks to invest in communication and storage. CDP Capital-Technology Ventures was launched in 1995 and is an operating subsidiary of CDP Capital – Private Equity.

Investments

Number of Investments
Number of Lead Investments
25
2
CDP Capital Technology Ventures has made 25 investments. Their most recent investment was on Jul 29, 2009, when Innodia raised $3M.
Date Company Name
Round Money Raised Industry Lead Investor
Jul 29, 2009 Innodia
Series Unknown $3M Biotechnology
Jul 12, 2007 TargeGen
Series D $40M Biopharma
Series B $24.40M Medical
Series B $25M Biopharma
May 9, 2005 Entrisphere
Series C $75M Internet

Exits

CDP Capital Technology Ventures has had 10 exits. CDP Capital Technology Ventures most notable exits include TransMedics ,   CymaBay Therapeutics

Date Company Name Exit Type Industry
May 1, 2019 TransMedics IPO Health Care Detail
Jul 18, 2014 CymaBay Therapeutics IPO Biopharma Detail
May 17, 2011 SiGe Semiconductor M&A Consumer Electronics Detail
Feb 2, 2011 NeoPhotonics M&A Communications Infrastructure Detail
Jun 30, 2010 TargeGen M&A Biopharma Detail